Bayer Pledges to Fix Legal Woes With Profit Set to Fall

Bayer AG forecast another year of falling profit and opted to stick with its conglomerate structure for now as it works to get on top of billions of dollars of legal woes that threaten the company’s long-term future.

The German crop sciences to pharma business, whose value has plunged by more than 70% since the $63 billion acquisition of Monsanto, said that splitting the business might seem like a quick fix to its multitude of problems, but it would likely make them worse.